Exogenus Therapeutics与Lonza合作开发符合GMP标准的主要外泌体候选药物生产工艺 - 基因工程与生物技术新闻

Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate  GEN - Genetic Engineering and Biotechnology News